| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | US20020006946 Obesity, antidiabetic agents, cardiovascular disorders |
| 01/17/2002 | US20020006917 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | DE10031651A1 Extrakte aus Sophora-Arten, Verfahren zu ihrer Herstellung und Verwendung Extracts of Sophora species, processes for their preparation and use |
| 01/17/2002 | DE10031650A1 Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden The use of extracts from Sophora flavescens or Sophora subprostrata for the prophylaxis and treatment of pathological conditions caused by estrogen deficiency or by other hormonal dysregulation |
| 01/17/2002 | CA2415093A1 Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x |
| 01/17/2002 | CA2415080A1 Improved thyroid hormone formulations |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2412142A1 A combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 01/16/2002 | EP1172113A1 Remedies for autonomic neuropathy |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171465A2 Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171444A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171135A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171125A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171121A2 Pharmaceutical compositions comprising dipeptidylpeptidase iv inhibitors for the promotion of growth |
| 01/16/2002 | EP1171120A1 Methods for alleviating discomfort of a hot flash and compositions therefor |
| 01/16/2002 | EP1171119A1 Methods of treating clinical diseases with isoflavones |
| 01/16/2002 | EP1171100A1 Solubilized pharmaceutical composition for parenteral administration |
| 01/16/2002 | EP0817645B1 Use of gonadotropin in the treatment of benign prostatic hypertrophy |
| 01/16/2002 | CN1330925A Instant bee pollen and its preparing process |
| 01/15/2002 | US6339086 Administering n-desmethylzopiclone, or its pharmaceutically acceptable salt, solvate, hydrate, or clathrate for prophylaxis or therapy of anxiety |
| 01/15/2002 | US6339079 Steroid sulfamates, method for the production and use thereof |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002564A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002144A1 Medicinal preparations for treating sex hormone-dependent diseases |
| 01/10/2002 | WO2002002113A1 Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002112A1 Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002107A1 Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002099A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
| 01/10/2002 | WO2002002076A2 Methods for treating inflammation-mediated conditions of the eye |
| 01/10/2002 | WO2002001969A1 Vitamin k and essential fatty acids |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001043762A3 Polypeptide compositions with improved stability |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001021191A3 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 01/10/2002 | US20020004496 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
| 01/10/2002 | US20020004209 Detecting modulators of transcription; incubate cell containing human androgen and estrogen receptors, preferential protein and modulator, monitor cell for adjustment in transcriptional activity |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412620A1 Vitamin k and essential fatty acids |
| 01/10/2002 | CA2410945A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170008A1 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169338A2 Low-molecular inhibitors of complement proteases |
| 01/09/2002 | EP1169336A1 Ent-steroids as selectively active estrogens |
| 01/09/2002 | EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/09/2002 | EP1169244A2 Metering valve |
| 01/09/2002 | EP1169058A1 Insulin-like growth factor binding protein-4 protease |
| 01/09/2002 | EP1169053A1 Pulmonary administration of dry powder formulations for treating infertility |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | CN1330655A Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/09/2002 | CN1329906A Clots dispersing medicine 'Huayudan' |
| 01/09/2002 | CN1329886A Medical percutaneous preparation containing hydrophilic or salt form |
| 01/08/2002 | US6337075 Methods for treating diabetes |
| 01/08/2002 | CA2143263C Orally administrable raloxifene formulations |
| 01/03/2002 | WO2002000727A2 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
| 01/03/2002 | WO2002000688A1 Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient |
| 01/03/2002 | WO2002000682A1 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 01/03/2002 | WO2002000681A1 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2002000237A1 Therapeutical use of sophora flavescens or sophora subprostrata extracts |
| 01/03/2002 | WO2002000236A1 Extracts from sophora species, method for producing the same and their use |
| 01/03/2002 | WO2002000227A2 Use of lanthanum compounds for the treatment of bone diseases |
| 01/03/2002 | WO2002000207A1 The controlled release preparation of insulin and its method |
| 01/03/2002 | WO2002000172A2 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 01/03/2002 | WO2002000017A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001058919A9 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001045689A3 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 01/03/2002 | WO2001044260A3 Novel purines |
| 01/03/2002 | WO2001043749A3 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 01/03/2002 | WO2001042265A3 N6 heterocyclic 8-modified adenosine derivatives |
| 01/03/2002 | US20020002283 Process for preparing growth hormone secretagogues |
| 01/03/2002 | US20020002186 Pharmaceutical composition |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | US20020002156 Androgenic steroid compounds and a method of making and using the same |
| 01/03/2002 | US20020002149 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors |
| 01/03/2002 | US20020002138 For use in treatment of diseases associated with reduced levels of growth hormone |
| 01/03/2002 | US20020002137 Combination of growth hormone secretagogues and antidepressants |